Experience

Vici Health Sciences

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Co-Founder and CEO

  • Aug 2014 - Present

  Vici Health Sciences is a pharmaceutical research company focused on the development and manufacturing of generic and branded prescription drug products for the US market. Our mission is to provide industry-leading value to our partner through good science, excellent execution and continuous improvement. We are able to work with our various development and manufacturing partners in the Northeast USA to deliver high quality products for our partners and customers. Vici Health Sciences is a pharmaceutical research company focused on the development and manufacturing of generic and branded prescription drug products for the US market. Our mission is to provide industry-leading value to our partner through good science, excellent execution and continuous improvement. We are able to work with our various development and manufacturing partners in the Northeast USA to deliver high quality products for our partners and customers.



WES Pharma

• Westminster MD

• VP Product Development

  • Aug 2014 - Feb 2016

  Oversee drug product development and serve as technical expert for formulation development. Assist in selection of new products and technologies for company. Oversee drug product development and serve as technical expert for formulation development. Assist in selection of new products and technologies for company.



GSK

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Principal Scientist/Team Lead

  • Mar 2013 - Aug 2014

  - Led the central formulation, analytical and manufacturing process development team responsible for GSK Consumer Healthcare’s global billion dollar acetaminophen (paracetamol, APAP) business comprising of over 10 dosage form platforms in 30+ countries around the world. - Organized a cross-functional team to handle responses to regulatory agency queries for the Panadol line of products, the team successfully handled responses for over 20 products in 10 different countries. - Led the central formulation, analytical and manufacturing process development team responsible for GSK Consumer Healthcare’s global billion dollar acetaminophen (paracetamol, APAP) business comprising of over 10 dosage form platforms in 30+ countries around the world. - Organized a cross-functional team to handle responses to regulatory agency queries for the Panadol line of products, the team successfully handled responses for over 20 products in 10 different countries.



CorePharma®

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Manager, Formulation R&D

  • Mar 2011 - Mar 2013

  - Managed a group of seven formulators and engineers leading the development of 10 ANDA projects, including complex dosage forms, controlled release formulations, paragraph IV filings, and CII products. - Demonstrated matching bioequivalence, including partial AUC, under fed and fasted conditions for multiple products. - Responsible for initiating and maintaining all technical and non-technical aspects of third party CMO relationships. - Developed CII controlled substance handling procedures and authored and reviewed various departmental procedures and SOPs. - Designed and implemented lab safety procedures for narcotic and potent drug handling. Managed formulation lab safety and equipment upgrades. Show less



Covidien (Medtronic Minimally Invasive Therapies Group)

• United States
• Medical Equipment Manufacturing
• 700 & Above Employee

• Sr. Research Associate

  • Oct 2005 - Mar 2011

  - Led a team of up to 14 formulators and analysts developing two NDA 505(b)(2) products across three geographical locations. One of the two products, Xartemis XR® is currently in the market and generates a revenue of over $40 million/year. The other product is currently under FDA review. - Extensive hands-on experience in process scale-up through designing and executing at least 40 scale-up campaigns at 8 different manufacturing facilities for 5 different products. - Successfully developed and scaled up complex controlled release product that has been filed after successful fasted and fed clinical study including matching partial AUC criteria. The product is currently under paragraph IV litigation. Show less



Pfizer

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Postdoctoral Research Experience

  • Aug 2004 - Oct 2005

  Developed and experimentally tested a population balance model describing high shear wet granulation and milling. Developed and experimentally tested a population balance model describing high shear wet granulation and milling.